Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease — RISE

COPD Patients Clinical Trial

Official title:
A Phase IIIB, 6-Month, Double-blind, Double-dummy, Randomized, Parallel-group, Multicenter Exacerbation Study of Symbicort® Pressurized Metered-Dose Inhaler (pMDI) 160/4.5 μg x 2 Actuations Twice-daily Compared to Formoterol Turbuhaler 4.5 μg x 2 Inhalations Twice-daily in Cronic Obstructive Pulmonary Disease (COPD) Patients.

Status Completed

Clinical Trial Summary

Comparing the efficacy of Symbicort® pMDI and Formoterol Turbuhaler in reducing exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD).

Clinical Trial Description

A Phase IIIB, 6-Month, Double-blind, Double-dummy, Randomized, Parallel-group, Multicenter Exacerbation Study of Symbicort® pMDI 160/4.5 μg x 2 Actuations Twice-daily Compared to Formoterol Turbuhaler 4.5 μg x 2 Inhalations Twice-daily in COPD Patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02157935
Study type	Interventional
Source	AstraZeneca
Contact
Status	Completed
Phase	Phase 3
Start date	June 27, 2014
Completion date	February 8, 2016

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05980611` - Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients
Recruiting	`NCT00949195` - Pulmonary Arterial Pressure Response During Exercise	N/A
Completed	`NCT06128902` - The Effect of Home-Based Monitoring, Exercise Training	N/A
Completed	`NCT01475812` - Daily Activities Are Sufficient to Induce Dynamic Pulmonary Hyperinflation and Dyspnea in Chronic Obstructive Pulmonary Disease Patients	N/A
Completed	`NCT01183052` - Mitochondrial Dysfunction and Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD) Patients	N/A
Withdrawn	`NCT00180622` - Markers for Chronic Obstructive Pulmonary Disease (COPD)
Completed	`NCT04869033` - Effects of Farinelli's Breathing Exercise in COPD Patients	N/A
Completed	`NCT02099279` - Prognostic Value Cardiac Dysfunction Assessed by Bedside Echocardiography in Critically Ill COPD Patients Requiring Mechanical Ventilation	N/A
Withdrawn	`NCT00361426` - EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients	N/A
Recruiting	`NCT03774238` - Determinants of the Vascular Response to Training in Chronic Obstructive Pulmonary Disease (COPD) Patients	N/A
Enrolling by invitation	`NCT03851991` - The Efficacy and Safety of Arbidol in Reducing the Frequency of AECOPD.	Phase 4